New: NCI-funded clinical trial search
Mednet Logo

How would you treat metastatic colon cancer in patients on dialysis?

What would you consider in the first and second line settings with intact MMR/MSI?
2 Answers
Mednet Member
Mednet MemberInvited Expert
Medical Oncology · Johns Hopkins University School of Medicine
Answered on

Fortunately, our standard regimen of 5FU and oxaliplatin are quite safe to administer for patients with chronic renal insufficiency/on dialysis:

- 5FU is cleared through non-renal mechanisms and does not require any dose adjustments

- BUT...exposure to capecitabine is higher in patients with renal i...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Medical Oncology · Rutgers Cancer Institute of New Jersey
Answered on

I generally agree with Dr Pishvaian. I would like to emphasize that capecitabine is completely contraindicated. Dose should be reduced for GFR < 30 ml/min but this is not safe for dialysis patients and cannot be given on a continuous basis.

Neither FU or platinums need any dose adjustment and I usua...

Join for free or sign in to see the full answer